- Home
- BFH vs TARS Comparison
BFH vs TARS Comparison
Compare BFH & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFH | TARS |
|---|---|---|
| Founded | 1996 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 3.6B |
| IPO Year | 2000 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BFH | TARS |
|---|---|---|
| Price | $101.82 | $74.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 17 | 10 |
| Target Price | ★ $115.00 | $99.50 |
| AVG Volume (30 Days) | ★ 518.5K | 517.3K |
| Earning Date | 10-22-2026 | 11-03-2026 |
| Dividend Yield | ★ 0.91% | N/A |
| EPS Growth | ★ 98.36 | 48.21 |
| EPS | ★ 7.72 | N/A |
| Revenue | ★ $4,521,400,000.00 | $451,360,000.00 |
| Revenue This Year | $4.40 | $59.75 |
| Revenue Next Year | $3.51 | $28.60 |
| P/E Ratio | $13.14 | ★ N/A |
| Revenue Growth | N/A | ★ 146.71 |
| 52 Week Low | $57.11 | $53.89 |
| 52 Week High | $114.53 | $91.53 |
Technical Indicators
Market Signals| Indicator | BFH | TARS |
|---|---|---|
| Relative Strength Index (RSI) | 47.72 | 47.88 |
| Support Level | $93.39 | $60.95 |
| Resistance Level | $105.20 | $79.10 |
| Average True Range (ATR) | 3.05 | 2.68 |
| MACD | 0.18 | -0.60 |
| Stochastic Oscillator | 74.38 | 42.53 |
Price Performance
Historical ComparisonAbout BFH Bread Financial Holdings Inc.
Formed by a combination of JCPenney's credit card processing unit and The Limited's credit card bank business, Bread Financial is a provider of private-label and co-branded credit cards, loyalty programs, and marketing services. The company's most financially significant unit is its credit card business, which partners with retailers to jointly market Bread's credit cards to their customers. The company also retains a minority interest in spun-off LoyaltyOne, which operates the largest airline miles loyalty program in Canada and offers marketing services to grocery chains in Europe and Asia.
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.